Valent Pharma Target Raised after Acquisition and 4 Stock Analyses to Know Now
Valeant Pharmaceuticals International (NYSE:VRX) target has been increased by Deutsche Bank due to the completion of the company’s Medicis acquisition. The firm maintains its Buy rating on the stock.
American Vanguard Corp. (NYSE:AVD): According to Piper Jaffray, investor concerns regarding the increased competition for American Vanguard’s corn soil insecticide products are overblown. Piper believes that investors should take advantage of the recent pullback in shares. The firm reiterates its Overweight rating and its price target to $38 from $41 on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA): William Blair continues to be convinced that the sell-off in shares of ARIAD on Iclusig’s product label was excessive, and the firm believes that there is a buying opportunity at current levels. William Blair maintains its Outperform rating and a $28 price target on the stock.
Tractor Supply Company (NASDAQ:TSCO) has been added to the short-term buy list at Deutsche Bank.
Computer Sciences Corporation (NYSE:CSC): According to Wells Fargo, CSC’s $475 million infrastructure contract with the FDIC has been overturned due to a protest by the incumbent contractor, SRA. This contract is now to be re-bid and SRA should keep receiving revenue from FDIC in the meantime, according to Wells Fargo. Furthermore, CSC was expected to receive significant revenue from the deal during the quarter, according to Wells, who decided to keep its Market Perform rating on the stock.